Clinical trials in Anderlecht – page 34

441 clinical trials in Anderlecht, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Anderlecht at a glance

441

clinical trials

Research sites2

Quick filters

441 trials in Anderlecht

Open in trial search

Breast cancer+1

Not recruiting

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Novartis Pharma AG

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Study on Batoclimab for Patients with Thyroid Eye Disease

InvestigationalNo placebo

Study on Batoclimab for Patients with Thyroid Eye Disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Batoclimab
Sponsor:Immunovant Sciences GmbH

Contact Research Centre

Glioblastoma multiforme+1

Not recruiting

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Registered drugNo placebo

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Temozolomide
Sponsor:Centre Oscar Lambret

Contact Research Centre

Hidradenitis

Not recruiting

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Hypertrophic cardiomyopathy

Not recruiting

Long-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials

InvestigationalNo placebo

Long-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Mavacamten
Sponsor:Myokardia Inc.

Contact Research Centre

Chronic lymphocytic leukaemia+1

Not recruiting

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

InvestigationalNo placebo

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ibrutinib
Sponsor:Janssen Cilag International

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Filgrastim
Sponsor:Pharma Mar S.A.

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational

Belgium

Participants:18–64 years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Crohn's disease

Not recruiting

Study on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery

Registered drugNo placebo

Study on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Infliximab
Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Doxorubicin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Investigational

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Seralutinib
Sponsor:GB002 Inc.

Contact Research Centre

Biliary neoplasm

Not recruiting

Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

Registered drug

Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Anderlecht

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials investigating new treatments for various cancers, including bladder cancer, acute myeloid leukemia, and advanced breast cancer. Studies focus on innovative combination therapies and targeted treatments.

Non-muscle invasive bladder cancer therapy
Metastatic breast cancer treatments
Gastroesophageal cancer interventions

02 Immunology and Inflammatory Conditions

Clinical investigations targeting chronic inflammatory conditions and autoimmune disorders, including Crohn's Disease, Ulcerative Colitis, and Psoriatic Arthritis.

Inflammatory bowel disease therapies
Novel arthritis treatments
Sjögren's Disease interventions

03 Infectious Diseases

Studies examining innovative approaches to combat various infections, including urinary tract infections and viral diseases. Research includes vaccine development and antimicrobial therapies.

UTI vaccine development
RSV vaccination studies
Hepatitis D treatments

04 Cardiovascular and Pulmonary Studies

Research focusing on pulmonary hypertension and cardiovascular disease management, with emphasis on innovative therapeutic approaches and disease prevention.

Pulmonary arterial hypertension treatments
Cardiovascular disease interventions
Post-cardiac arrest care

Back to Belgium All countries